New personalised therapy targets chronic blood cancer

Дата публикации: 02-07-2026 09:44:00

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies	0	9.03	19-05-2026
2	Inherited gene variants may shape CAR-T therapy benefits and toxic side effects	0	8.44	24-07-2026
3	Новое лекарство от агрессивных видов рака крови создают в Петербурге	6	7	17-07-2026
4	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
5	Inherited genetics can influence safety and success of CAR-T cell therapy	0	12.03	24-07-2026
6	Breakthrough for patients with pancreatic cancer as doctors develop new blood test that can pick up 'residue cells' of the 'silent' disease that killed Alan Rickman	8	7	30-06-2026
7	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
8	Study reveals blood stem cells can ‘remember’ inflammation	0	6.57	27-05-2026
9	New, improved method to find and isolate the strongest cancer-fighting immune cells	7	8	08-07-2026
10	Ученые нашли способ создать источник клеток для борьбы с раком	5	7	06-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.58. Источник: www.imm.ox.ac.uk.